Literature DB >> 18605959

Quality indicators and specifications for strategic and support processes in laboratory medicine.

Carmen Ricós1, Carme Biosca, Mercè Ibarz, Joana Minchinela, Maantonia Llopis, Carmen Perich, Jesus Alsina, Virtudes Alvarez, Vicenta Doménech, Rosa Ma Pastor, Mireia Sansalvador, Gloria Trujillo Isern, Conrad Vilanova Navarro.   

Abstract

BACKGROUND: This work is the second part of a study regarding indicators and quality specifications for the non-analytical processes in laboratory medicine. Five primary care and five hospital laboratories agreed on the indicators for two strategic processes (quality planning and project development) and various support processes (client relationships, instrument and infrastructure maintenance, safety and risk prevention, purchases and storage, personnel training).
METHODS: In the majority of cases, the median values recorded over 1 year is considered to be the state-of-the-art in our setting and proposed as the quality specification for the indicators stated. Values have been stratified according to primary care and hospital laboratory for referred tests and group of personnel for training. In some cases, the specifications have been set equal to zero events, such as serious incidents in the infrastructure maintenance process and number of work accidents in the safety and risk prevention process. RESULTS AND
CONCLUSIONS: In light of this study, an effort is needed to optimize decisions regarding corrective actions and to move from a subjective individual criterion to systematic and comparative management. This preliminary study provides a comprehensive vision of a subject that could motivate further research and advances in the quality of laboratory services.

Mesh:

Year:  2008        PMID: 18605959     DOI: 10.1515/CCLM.2008.225

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  1 in total

Review 1.  History of the preanalytical phase: a personal view.

Authors:  Walter G Guder
Journal:  Biochem Med (Zagreb)       Date:  2014-02-15       Impact factor: 2.313

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.